Silicone scar treatment preparation

1. A method for preparing a spreadable composition for topical application comprising:

(a) providing a volatile component, a volatile coagent, and an active component; and

(b) mixing the volatile component, the volatile coagent, and the active component with siloxane matrix precursors thereby forming the spreadable preparation; wherein:

(i) the volatile component is a cyclic siloxane present in the composition at a concentration ranging from 12 wt % to 45 wt % of the overall composition;

(ii) the siloxane matrix precursors having dimethicone and dimethicone cross polymers and ranging from 25 wt % to 60 wt % of the overall composition;

(iii) an active component solubilized in the spreadable composition, the active component comprising a corticosteroid or an agent having sun screening activity; and

(iv) the volatile coagent being present in the composition at a concentration ranging from 5 wt % to 50 wt % of the overall composition and including at least one selected from the group consisting of dimethyl isosorbide, pentylene glycol, and isopropyl myristate.

2. The method of claim 1 , wherein the volatile component is cyclopentasiloxane.

3. The method of claim 1 , wherein the active component comprises hydrocortisone or an agent having sun screening activity, the agent having sun screening activity comprising octinoxate and octisalate.

4. The method of claim 1 , wherein the active component is an agent having sun screening activity, the agent having sun screening activity comprising at least three agents selected from the group consisting of octinoxate, octisalate, octocrylene, and oxybenzone.

5. The method of claim 1 , wherein the active component is hydrocortisone acetate at a concentration ranging from 0.5 wt % to 3 wt % of the overall composition.

6. The method of claim 1 , wherein the siloxane matrix precursors further comprise fumed silica.

7. A composition for topical application, the composition comprising:

a) a volatile component having a cyclic siloxane and being present in the composition at a concentration ranging from 12 wt % to 45 wt % of the overall composition;

b) siloxane matrix precursors at a concentration ranging from 25 wt % to 60 wt % of the overall composition:

c) an active component solubilized in the spreadable composition; and

d) a volatile coagent being present in the composition at a concentration ranging from 5 wt % to 50 wt % of the overall composition and including at least one selected from the group consisting of dimethyl isosorbide, pentylene glycol, and isopropyl myristate, wherein:

the active component includes a corticosteroid ranging from 0.5 wt % to 3 wt % or an agent having sun screening activity, and

the siloxane matrix precursors are capable of polymerization to form a siloxane matrix.

8. The composition of claim 7 , wherein the volatile component comprises cyclopentasiloxane.

9. The composition of claim 7 , wherein the silioxane matrix precursors comprise dimethicone and dimethicone crosspolymer.

10. The composition of claim 7 , wherein the siloxane matrix precursors comprise dimethicone crosspolymer and fumed silica.

11. The composition of claim 7 , wherein the siloxane matrix precursors comprise dimethicone, dimethicone crosspolymer, and fumed silica.

12. The composition of claim 7 , wherein the active component is the agent having sun screening activity comprising octinoxate and octisalate.

13. The composition of claim 7 , wherein the active component is the agent having sun screening activity comprising at least three agents selected from the group consisting of octinoxate, octisalate, octocrylene, and oxybenzone.

14. The composition of claim 7 , wherein the active component is hydrocortisone acetate at a concentration ranging from 0.5 wt % to 3 wt % of the overall composition.

15. The composition of claim 11 , wherein the volatile coagent comprises 10 wt % to 25 wt % of the overall composition.